Search

Mamta Kalra

from Sugar Land, TX
Age ~48
Get Report
Also known as:
Mamta Karla
Connected to:
Archana Kalra, 47Disha Kalra, 45Esha Kalra, 44Gunjan Kalra, 50Jasbir K Kalra, 66Jasjit S Kalra, 43Manisha Kalra, 47Narendra J Kalra, 88Navdeep Kalra, 42Nikhil Kalra, 27

Mamta Kalra Phones & Addresses

  • Sugar Land, TX
  • Houston, TX
  • Tulsa, OK

Resumes

Resumes

Mamta Kalra Photo 1

Lead Teacher

View page
Location:
Houston, TX
Industry:
Education Management
Work:
Tree of Life Preschool
Lead Teacher
Timberlake Christian Preschool Jul 2018 - Dec 2018
Lead Preschool Teacher
Bellevue Crossroads Preschool Jul 2018 - Sep 2018
Lead Teacher
Diablo Hills Country School Jul 2017 - Jul 2018
Lead Preschool Teacher
Little Bridge Ltd Jul 2016 - Jul 2017
Lead Preschool Teacher
Education:
University of Califonia - Silicon Valley 2016 - 2017
Skills:
Lesson Planning
Early Childhood Education
Teaching
Classroom Management
Preschool
Mamta Kalra Photo 2

Associate Director, Cmc

View page
Location:
Houston, TX
Industry:
Pharmaceuticals
Work:
PGI 2000 - 2005
Phd student
Education:
Post Graduate Institute of Medical Sciences 2000 - 2005
Doctorates, Doctor of Philosophy, Philosophy, Immunology Post Graduate Institute of Medical Sciences 1997 - 1999
Masters, Biotechnology
Skills:
Molecular Biology
Statistics
Biotechnology
Biochemistry
Data Analysis
Pcr
Cell Culture
Scientific Writing
Clinical Research
Microscopy
Mamta Kalra Photo 3

Mamta Kalra

View page
Mamta Kalra Photo 4

Mamta Kalra

View page

Publications

Us Patents

Cd8 Polypeptides, Compositions, And Methods Of Using Thereof

View page
US Patent:
20220202862, Jun 30, 2022
Filed:
Dec 28, 2021
Appl. No.:
17/563599
Inventors:
- Houston TX, US
Mamta KALRA - Houston TX, US
Melinda MATA - Houston TX, US
International Classification:
A61K 35/17
C12N 15/86
C12N 5/0783
C07K 14/725
C07K 14/705
Abstract:
The present disclosure relates to T cells capable of co-expressing T cell receptors (“TCR”) together with CD8 polypeptides and the use thereof in adoptive cellular therapy. The present disclosure further provides for modified CD8 sequences, vectors, and associated methods thereof.

Monocyte Depletion Of T Cells Populations For T-Cell Therapy

View page
US Patent:
20230089392, Mar 23, 2023
Filed:
Sep 19, 2022
Appl. No.:
17/933418
Inventors:
- Houston TX, US
Pooja MEHTA - Houston TX, US
Mamta KALRA - Houston TX, US
International Classification:
C12N 5/0783
C07K 14/725
C07K 14/705
C07K 14/74
Abstract:
A method for producing an engineered T cell population includes obtaining a cell population containing a monocyte and a T cell, resting the obtained cell population on a surface, adhering the monocyte to the surface, retaining a non-adherent cell population, activating the non-adherent cell population, introducing a nucleic acid into the activated non-adherent cell population to obtain a transformed T cell, and expanding the transformed T cell to obtain the engineered T cell population.

Wpre Mutant Constructs, Compositions, And Methods Thereof

View page
US Patent:
20210285011, Sep 16, 2021
Filed:
Mar 10, 2021
Appl. No.:
17/197927
Inventors:
- Houston TX, US
Mamta KALRA - Sugar Land TX, US
Yannick BULLIARD - Thousand Oaks CA, US
Steffen WALTER - Houston TX, US
Ali MOHAMED - Sugar Land TX, US
International Classification:
C12N 15/86
C12N 15/10
C07K 14/725
C12N 15/113
Abstract:
The present invention provides a mutated woodchuck post-transcriptional regulatory element (WPRE). In particular, the present invention relates to a mutated WPRE sequence that can efficiently express nucleotides of interest in a retroviral vector system. The present invention also relates to methods of delivering and expressing nucleotides of interest to a target cell.

Viral Vectors And Use Thereof In Adoptive Cellular Therapy

View page
US Patent:
20200376031, Dec 3, 2020
Filed:
May 27, 2020
Appl. No.:
16/884804
Inventors:
- Houston TX, US
Yannick Bulliard - Sugar Land TX, US
Mamta Kalra - Houston TX, US
International Classification:
A61K 35/17
C07K 14/705
C07K 14/725
C12N 15/64
C12N 5/078
Abstract:
A vector containing a first nucleotide sequence S1 encoding a protein Z1, a second nucleotide sequence S2 encoding a protein Z2, a third nucleotide sequence S3 encoding a protein Y1, and a fourth nucleotide sequence S4 encoding a protein Y2, in which Z1 and Z2 form a first dimer and Y1 and Y2 form a second dimer, in which the first dimer Z1Z2 is different from the second dimer Y1Y2.

Cd28 T Cell Cultures, Compositions, And Methods Of Using Thereof

View page
US Patent:
20200297768, Sep 24, 2020
Filed:
Mar 19, 2020
Appl. No.:
16/823987
Inventors:
- Houston TX, US
Mamta KALRA - Houston TX, US
International Classification:
A61K 35/17
A61P 35/00
C12N 15/86
C12N 5/0783
Abstract:
A method for producing T cells with improved efficacy for adoptive immunotherapy includes obtaining a population of CD8+ T cells from a patient or a donor, determining a % of CD28+CD8+ T cells in the obtained population, activating the determined population with anti-CD3 antibody and anti-CD28 antibody, provided that the determined population comprises at least 50% of CD28+CD8+ T cells, or activating the determined population with anti-CD3 antibody in the absence of anti-CD28 antibody, provided that the determined population comprises less than 50% of CD28+CD8+ T cells, transducing the activated population with a viral vector, and expanding the transduced population, in which the transducing and the expanding are carried out in the presence of at least one cytokine.
Control profile
Mamta Kalra from Sugar Land, TX, age ~48 Get Report